Related Experiment Video
Updated: Apr 15, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Diagnostic Aspects of a Bacillus Calmette-Guërin (BCG) Infection Following Intravesical Treatment for Bladder Cancer
Background:
Bacillus Calmette-Guérin (BCG) infection is a rare complication of intravesical immunotherapy for bladder cancer. Distinguishing Mycobacterium bovis BCG from other Mycobacterium tuberculosis complex members is crucial due to intrinsic drug resistance.
Methods:
We report a case of BCG infection following intravesical immunotherapy and propose three laboratory clues.
Results:
White, spreading umbonate colony morphology; negative M. tuberculosis protein 64 (MPT-64) antigen test; and nearly identical cycle threshold values for insertion sequence 6110 (IS6110) and internal transcribed spacer targets in real-time PCR strongly suggest BCG infection.
Conclusions:
These findings could facilitate the rapid identification of M. bovis BCG and appropriate treatments.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Imaging Studies VI: Voiding Cystourethrography and Cystography
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

